A B S T R A C T The insulin and gastrin response to oral glucose, intravenous glucose, or a protein-rich meal were measured in 44 nondiabetic patients with pernicious anemia (PA) and in 44 control subjects. 36 of the PApatients had hypergastrinemia, while serum gastrin concentrations in the remaining eight patients were below normal. Three hypergastrinemic PA-patients were in addition studied during an oral glucose loading with synchronous intravenous infusion of gastrin-17.
A B S T R A C T The insulin and gastrin response to oral glucose, intravenous glucose, or a protein-rich meal were measured in 44 nondiabetic patients with pernicious anemia (PA) and in 44 control subjects. 36 of the PApatients had hypergastrinemia, while serum gastrin concentrations in the remaining eight patients were below normal. Three hypergastrinemic PA-patients were in addition studied during an oral glucose loading with synchronous intravenous infusion of gastrin-17.
During both oral and intravenous glucose tests blood glucose concentrations were similar in patients and in controls. After ingestion of protein blood glucose concentrations in PA-patients with hypergastrinemia were above those of the controls (P <0.05). Parenteral infusion of gastrin-17 during oral glucose loading also increased blood glucose concentrations above the levels observed after glucose alone. In PA-patients with hypergastrinemia the insulin response was augmented in all tests. In patients with hypogastrinemia serum insulin concentrations were lower than normal in the fasting state and during stimulation with glucose intravenously (P < 0.01). In hypergastrinemic patients serum gastrin concentrations decreased after oral as well as intravenous glucose administration. The decrease was larger during the oral test. In hypogastrinemia oral glucose induced, as in controls, a small initial rise followed by a slow fall in serum gastrin concentrations. No variations were seen in these patients during the intravenous glucose infusion. Gel filtration of serum from hypergastrinemic patients disclosed a decrease in the concentrations of all Dr. Rehfeld's present address is Institute of Medical Biochemistry, University of Aarhus, DK-8000 Aarhus C, Denmark.
INTRODUCTION
Exogenous gastrin in form of the heptadecapeptide amide (gastrin-17)1 and its C-terminal tetrapeptide amide can stimulate insulin release in man (1) (2) (3) . But dose-response studies with exogenous gastrin-17 correlated to endogenous gastrin concentrations in serum during meals point to a limited role of gastrin in the regulation of insulin secretion in normal human subjects (4) . However, since gastrin-17 in high doses releases large amounts of insulin and moreover increases blood glucose concentrations (4), endogenous hypergastrinemia might also influence insulin secretion and glucose metabolism.
Endogenous hypergastrinemia is most often found in patients with achlorhydria, among which those with pernicious anemia (PA) constitute a well-defined group. Approximately 75% of PA-patients have increased concentrations of gastrin in serum (5) . A relationship be-autoimmune nature (10) (11) (12) (13) (14) . But diabetes mellitus of maturity-onset type in PA might be due, at least in part to hypergastrinemia.
The present study is an attempt to evaluate whether the disturbed gastrin release in PA influences insulin secretion and glucose homeostasis.
METHODS
Patients and control subjects 44 patients with treated PA and 44 healthy control subjects participated in the study. All patients and controls were within 10% of their desirable weight (15) . The PAdiagnosis was established on the basis of analysis of vitamin B,2 concentration in serum, bone marrow examination, Schilling test without and with oral hog intrinsic factor, and an augmented histamine test. None of the patients had diseases other than PA, except five with vitiligo and two having rheumatoid arthritis. Neither diabetes mellitus nor thyroid diseases were known in the patients, nor had any been submitted to gastrointestinal surgery before the investigation.
The PA-patients were divided into three groups: 16.7 g glucose in concentrations from 33 to 50%o was given intravenously at a constant infusion rate. Termination of the infusion was aimed to coincide with the peak blood glucose concentration reached during the oral test in the same individual. Blood samples were drawn from the contralateral arm at the same intervals as those in the oral glucose test. The simple infusion test described here has been evaluated in detail elsewhere (16) . It is based on the observation that approximately one third of the glucose given orally escapes hepatic extraction in subjects with a normal glucose tolerance (17) .
Protein-rich meal. Group III of the PA-patients and the respective controls were given an appetizing meal composed of beefsteak, sauce, vegetables, and a glass of water. The meal was finished within 20 min. Blood samples were drawn 15, 10, and 5 min before, and 5, 10, 20, 30, 45, 60, and 90 min after the onset of the meal.
Intravenous gastrin infusion. In three PA-patients from group III, who previously were submitted to a 50-g oral glucose load, pure human nonsulfated gastrin-17, 2 pug/kg/h (a generous gift from Professor R. A. Gregory (4) . The antiserum employed binds monocomponent human insulin and human proinsulin with equimolar potency.
Serum gastrin. Concentrations were measured radioimmunochemically. Reagents, procedure, and reliability parameters for the assay have been described in detail previously (5, 18, 19) . In the present study antiserum no. 2604-g was employed (18) . Gastrin (27) . Until the serum components are characterized better and possible identity with tissue gastrin is proven the flexible component nomenclature should be used for circulating gastrins, whereas the rigid amino acid-number nomenclature can be maintained for the well-characterized tissue gastrins. 
Calculations
The integrated glucose stimulation and insulin response for each experiment were computed by planimetry of the area under the blood glucose and serum insulin curves in the time intervals indicated using the lowest levels observed as base line. The significance of differences between means was tested by Student's t test. The concentrations are given as mean+SEM. RESULTS
Response to oral glucose loading Group I ( Fig. 2 and Table I ). The blood glucose curves and the total glucose stimulation in patients were similar to that of controls. Serum insulin concentrations in the patients rose from 62±10 to 560+69 pmolafter 60 min. Controls showed an increase from 60±+10 to 371+45 pmol-l' in the same period. The mean peak concentration in PA was above normal (P < 0.01). So also were the insulin responses in the 0.5-2 h interval and the total insulin response (P < 0.05). Mean serum gastrin concentration in PA fell rapidly (P < 0.01).
The controls showed a small rise initially but otherwise displayed no variations in serum gastrin levels. Group II ( Fig. 3 and Table I ). Blood glucose concentrations rose faster than normal to a peak after 30 Group II (Fig. 5 and Table I ). Blood glucose curves and concentrations in patients and controls were similar. Serum insulin concentrations in the patients were L0 -l decreased both in the fasting state (P <0.01), and in 3 response to intravenous glucose being 38% of the normal response (P < 0.01). Serum gastrin concentrations in 20 patients were lower than normal throughout the test (P < 0.01) and showed no significant variations. Group III (Fig. 6 ). min. The controls reached peak concentration after 50 min from the same basal level. Serum insulin concentration in the patients in the fasting state was 32±14 pmol-1P1, which is below that of controls, 77+7 pmol 11 (P < 0.02). The rise of insulin concentration in patients after oral glucose was higher than normal (P < 0.05). After 1 h the insulin concentrations fell below those of the controls (P < 0.05), so that the entire insulin response to oral glucose in patients was similar to that of normal subjects (Table I ). The gastrin concentrations in the fasting PA-patients were lower than normal (P < 0.05).
The gastrin concentrations varied as in controls during glucose ingestion, but at a lower level.
Response to intravenous glucose infusion Group I (Fig. 4 and Table I ). Blood glucose curves were almost similar in patients and in controls. The total glucose stimulation in PA was normal although the patients had insignificantly higher glucose concentrations throughout the test. Serum insulin concentra- tients were above normal throughout the 90-min period after onset of the meal (P < 0.05). Serum insulin concentrations rose in PA-patients from 77±9 to 468±137 pmol' P-1 within 45 min, after which the concentrations were reduced to half the peak value. In control subjects the increase was from 82±6 to 234±40 pmol 11, which is below the peak concentration (P < 0.02). Serum gastrin concentrations in the patients rose within 10 min, and remained above basal concentrations throughout the test period. Control subjects responded rapidly to the food.
Insulin and Gastrin Secretion in Pernicious Anemia
Response to oral glucose loading combined with intravenous gastrin infusions (Fig. 7) Blood glucose concentrations were slightly enhanced after gastrin infusion, both in the basal state and during glucose ingestion in comparison to the levels found during the usual oral glucose tolerance test. Basal serum insulin concentrations rose immediately after onset of the gastrin infusion, and remained above control levels throughout the infusion period. Serum gastrin concentrations were doubled during the infusion period. Effect of oral and intravenous glucose administration on gastrin component pattern in serum (Table II) Comparison of components in the fasting state and at nadir showed unchanged patterns after intravenous glucose infusion. After oral glucose the concentration of all components was reduced.
DISCUSSION
The present study shows that both hyper-and hypogastrinemia are associated with abnormalities in insulin secretion. Moreover it shows that protein-rich food, which maintains enhanced gastrin levels in hypergastrinemia patients, increases blood glucose concentrations above normal in spite of hyperinsulinemia. Combination of these results with the dose-response study in normal subjects (4) , and the results of parenteral gastrin-infusion in PA suggest that gastrin may be important in regulation of islet-cell secretion in certain diseases.
Selection of patients with hypergastrinemia. In contrast to other diseases with increased serum gastrin levels achlorhydria is, in the form found in PA, useful for studies on the effect of endogenous hypergastrinemia on islet-cell function because: 1) gastrin in PA, as in normal subjects, is produced mainly by the antrum (28).
2) All evidence available so far indicates that circulating gastrins in normal subjects and PA-patients are qualitatively similar (20, 21, 27 ).
3) The increased gastrin release in PA is probably caused only by lack of inhibition from gastric acid, and the gastrins in serum are metabolized at a normal rate (29). 4) Zollinger-Ellison patients are unsuited for studies like the present in that gastrinomas often are associated with subclinical neoplasias of alpha-and beta cells (30, 31) . Insulin and glucagon secretion in the Zollinger-Ellison syndrome may consequently deviate a priori, and thereby invalidate studies on the insulinogenic effect of gastrin based on gastrinoma patients (32, 33) . Anyway, ZollingerEllison patients display increased insulin response to glucose and diabetic glucose tolerance (34) . 5) Gastrin secretion in duodenal ulcer patients is also abnormally increased, at least during meals (35, 36) . Serum levels in these patients and those of food-stimulated normal subjects (37) are, however, placed so much to the left on the dose-response curve (4) that it is difficult to demarcate insulinogenic effects of endogenous gastrins in these conditions. 6) Patients with severe kidney damage are hypergastrinemic, but their general metabolic derangement, including abnormal levels of betacytotrophic hormones other than gastrin, makes them unfit for studies like the present.
Little is known about secretion of hormones with betacytotrophic actions in PA other than gastrin. Secretin levels are apparently normal in PA (29) , but the secretion of other insulinogenic hormones in achlorhydria awaits further studies. So far there is, however, no reason to expect abnormal release of these hormones. Insulin secretion and glucose homeostasis in endogenous hypergastrinemia. Gastrin probably has a direct effect on the beta cell, since indirect actions through acid-induced release of duodenal hormones in achlorhydria is precluded. The suggestion that gastrin cannot act directly upon the beta cell (32) , because it has failed to stimulate insulin release from isolated islets (38, 39) is dubious, and reflects rather destruction of gastrin receptors during preparation of the isolated islets. The normal basal levels of insulin in fasting PA-patients with hypergastrinemia is in accordance with the observation that gastrin-17 has poor effect on basal insulin secretion, but potentiates the glucose-stimulated insulin release significantly even in moderate doses (4) .
Not only were insulin levels raised above normal in hypergastrinemic PA-patients, but blood glucose concentrations were abnormally enhanced when gastrin levels were not suppressed. Since ingestion of protein-rich food is a daily and frequent event, at least in some parts of tne world, hyperglycemia in this situation is important. The present study has shown that the food-induced hyperglycemia lasted more than 1.5 h after meals in hypergastrinemic patients, and the patients hence have long periods of abnormal hyperglycemia every day. The normal blood glucose variations during the unphysiological glucose tolerance test in these patients consequently mask their daily hyperglycemia by defining them as normal in respect to glucose tolerance.
There are reasons to believe that the above mentioned hyperglycemia in hypergastrinemia is due to increased gastrin stimulation of a2-cells: 1) gastrin stimulates glucagon secretion (40, 41) , also in doses which in normal subjects result in serum gastrin concentrations similar to those of the PA-patients in this study. in spite of an immediate insulin release (4). 2) The normal glucose concentrations in PA after glucose ingestion may reflect the fact that glucose administration suppresses glucagon secretion. However, since the insulin response to glucose is increased there is still an abnormal relative hyperglycemia after glucose ingestion, which may suggest that a2-cells are not normally suppressed by glucose in hypergastrinemia. This corresponds to the previous observation in normal subjects that addition of even small doses of gastrin to intravenous glucose potentiates the glucose-induced insulin release dramatically without increase of glucose assimilation (4).
Insulin secretion in endogenous hypogastrinemia. Hypogastrinemia in PA is probably caused by progression of atrophic gastritis from the fundic mucosa into the antrum (42, 43) . It was unexpected to find hypoinsulinism in these patients. The decrease in insulin concentrations was only significant during the intravenous glucose infusion, which may suggest that a certain basal gastrin level is necessary for a normal beta cell response to glucose. This is further supported by studies on patients with more pronounced hypogastrinemia due to resection of antrum, duodenum, and the proximal jejunum (Whipple's operation). These patients had similarly reduced insulin response to parenteral glucose administration (44) . The normal magnitude of the insulin response to oral glucose in hypogastrinemic PA is in accordance with the previously held view (4, 16, 44) that gastrin in normal and low concentrations plays only a small role as enteral insulin-stimulator during glucose ingestion. In contrast gastric inhibitory polypeptide may be responsible for most of the incremental effect after oral glucose (45, 46) . Hypoinsulinism in hypogastrinemia may explain why insulin secretion in PA was found normal in one study (47) and increased after oral glucose, but normal after intravenous glucose in another study (48) . PA-patients in these investigations were not subdivided according to gastrin levels, since gastrin measurements were not available at that time.
Insulin and Gastrin Secretion in Pernicious Anemia
The effect of glucose on serum gastrin components in endogenous hypergastrinemia. Endogenous gastrin circulates in four main components both in normal subjects and hypergastrinemic patients (20, 22, 49) . The gastrins are stimulated by protein-rich food (29, 49, 50) ; but, as shown in hypergastrinemic PA-patients, the concentration of the components is effectively depressed by oral glucose. The suppression is probably to a small extent due to direct inhibition of gastrin release by glucose per se, because intravenous glucose administration lowers the gastrin concentrations slightly (Figs. 4 and 5) . The mechanism behind the remaining fall in gastrin concentrations after oral glucose is unknown. A possibility is that gut hormones released by enteral glucose like entero-glucagon and GIP inhibits the secretion of gastrin.
The present study has not disclosed which of the gastrin components is most active and important in the regulation of insulin and glucagon secretion. Further dose-response studies are now needed to decide whether the various gastrins stimulate the endocrine pancreas in a molar ratio similar to their stimulation of gastric acid (26, 51 
